Accreditation / Credit Designation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Arizona College of Medicine - Tucson and Fetal Heart Society. The University of Arizona College of Medicine - Tucson is accredited by the ACCME to provide continuing medical education for physicians.
The University of Arizona College of Medicine – Tucson designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
University of Arizona College of Medicine - Tucson Office of Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.
Dr. Miwa Geiger has disclosed: Consulting Fee-Brightheart AI.
Dr. Luis Goncalves has disclosed: Honoraria-Philips.
Ms. Mishella Perez has disclosed: Speakers Bureau-GE Healthcare.
Dr. Jay Pruetz has disclosed: Membership on Advisory Committees or Review Panels, Board Membership, etc.-Vitara Biomedical Inc. |Consulting Fee-Prolacta Bioscience, Inc.
All other individuals in a position to control the content of this CME activity have disclosed that they have no relevant financial relationships with ineligible companies that would constitute a conflict of interest concerning this CME activity.
Outcome Objectives
-Adhere to OB cardiac screening guidelines.
-Incorporate into diagnosis sonographic findings of various forms of congenital heart disease and prenatal prediction of postnatal outcomes.
-Manage referral criteria and risks of fetal cardiac and extracardiac intervention.
-Provide improved, accurate fetal cardiac diagnosis and counseling to the maternal patient.
-Detect congenital heart disease with improved accuracy.
-Communicate to patients more effectively prenatal predictors of postnatal outcomes of congenital heart disease.
-Counsel patients on postnatal neurodevelopmental outcomes during prenatal counseling.
-Incorporate prenatal genetic evaluation for fetal cardiac disease.